Announcement on Convening Performance Briefing for 2025 and Q1 2026
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Announcement on Convening Performance Briefing for 2025 and Q1 2026
Filed with SSE · · 3 pages · Chinese
Release
North China Pharmaceutical Company Ltd. on 6ix
Earlier from North China Pharmaceutical
- Announcement on Release of Pledge and Pledge of Some Shares of Shareholders
- Notice on Convening the 2025 Annual General Meeting
- Announcement on Renewing Engagement of Accounting Firm
- Announcement on Receipt of Government Land Acquisition and Sale Proceeds Return Payments
- Announcement on Obtaining the Drug Registration Certificate by Subsidiary
Later from North China Pharmaceutical
- Announcement on Election of Employee Director
- Announcement on Implementation of Dividend Distribution for 2025
- Announcement on Obtaining Drug Registration Certificate
- Announcement on Inclusion of Products of the Company and Its Subsidiaries in the National Essential Medicines List
- Announcement on the Proposed Selection of Drugs of the Company and Its Subsidiaries in the National Centralized Drug Procurement
Follow North China Pharmaceutical into a list and get an email when it puts out news.
Follow North China Pharmaceutical